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Abstract A preliminary structural analysis of Vibrio cholerae
zonula occludens toxin (ZOT) was made by equilibrium dena-
turation and circular dichroism. ZOT is a structurally unstable
protein in aqueous solution (vGðH2OÞ 3.82 kcal/mol), the puta-
tive intra- and extracellular domains unfold co-operatively, with
complete denaturation via observed conformational intermedi-
ates. Refolding of denatured ZOT is not dependent on disul-
phide bridge formation. Partial refolding of a maltose binding
protein^ZOT fusion did not prevent its speci¢c binding to the
ZOT receptor on Caco-2 cells. Immuno-gold labelling showed
that the ZOT receptor localises to the intercellular contacts
between cells in a con£uent monolayer.
/ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Interest generated around Vibrio cholerae zonula occludens
toxin (ZOT) can largely be attributed to its unusual transient
loosening of the intestinal tight junctions (zonula occludens),
rather than an irreversible opening as seen with Clostridium
di⁄cile toxin A [1]. The tight junctions regulate the perme-
ability of solutes across the polarised epithelial cells at the
mucosal surface and by scanning electron microscopy
(SEM) are seen as a belt circumventing the cell at its apical
side [2]. Existing as membrane microdomains, these structures
are mainly composed of the occludin and claudin family of
transmembrane proteins and the zonula occludens-associated
proteins (ZO-1, 2, 3) [3^6].
Using in vivo perfusion assays, a 10-fold increase in insulin
permeability across the rabbit jejunal and ileal mucosa, but
not the colonic mucosa, was observed in response to ZOT [7].
The absence of a colonic response was seen as important
because compromising the integrity of the lower bowel would
facilitate pathogen in¢ltration. ZOT causes tight junction dis-
ruption between con£uent Caco-2 monolayers in culture
(although derived from an adenocarcinoma of the colon the
cells phenotypically di¡erentiate to enterocytes ^ small intes-
tinal cells), seen as a transient 60% drop in transepithelial
electrical resistance and increased permeation for certain
drugs [8].
The mechanism by which ZOT elicits tight junction disrup-
tion is understood for the most part at the cellular level and
partially at the molecular level. Micrographs of rabbit ileum
exposed to culture supernatants of V. cholerae showed loss of
strands perpendicular to the ZO axis, with the 10^30 kDa size
fraction reversibly increasing tissue conductance [1]. Later
work correlated the 10^30 kDa fraction to the ZOT C-termi-
nus [9], and screening overlapping C- and N-terminally trun-
cated ZOT constructs isolated a putative binding motif
G291RLCVQDG298, within the 135 residue C-terminal active
domain termed vG [10].
Western blot of protein preparations from intestine, heart
and brain for anti-ZOT antibody identi¢ed a 47 kDa
band, later termed zonulin, with N-terminal identity to
GRLCVQDG298 and a similar action on the intestinal epithe-
lium as ZOT [11]. A synthetic peptide analogue (GGVLV-
QPG) to the ZOT and zonulin putative binding motifs was
shown to partially inhibit the intestinal response to ZOT and
zonulin [10]. This octapeptide would not maintain any speci¢c
secondary structure but still inhibited ZOT binding to its pu-
tative receptor, showing that the GRLCVQDG298 putative
binding domain of ZOT is not entirely conformationally con-
strained. Further information regarding the structural mech-
anism of action ideally requires cloning and expression of the
putative ZOT receptor, which thus far has been isolated as a
66 kDa protein from Caco-2 cells and a 45 kDa protein from
human brain, heart and intestine [12,13].
Conformational analysis of ZOT has to date not been avail-
able, though its intracellular signalling requires protein kinase
C, and possibly phospholipase C, reducing the number of
transcellular actin ¢laments with concomitant reciprocal
changes to the F- and G-actin pools [14]. In this report we
intend to address the above issues by preliminary character-
isation of ZOT conformational stability with respect to recep-
tor binding, and provide data which may aid further inves-
tigations targeting the isolation of the putative ZOT receptor.
2. Materials and methods
2.1. Cloning procedures
Genomic DNA was prepared from V. cholera TRH7000, an atte-
nuated strain kindly provided by Prof. Hirst, University of Bristol
[15]. This strain was constructed by deletion of both ctxA/B genes
as previously described [16], that is: recombination of V. cholerae
N16961 with a plasmid (pJBK55) harbouring a 20 kb chromosomal
fragment of V. cholerae but with a L-lactamase gene substituted for
the ctxAB genes. Since deletion of the ctxAB genes was made by AccI
digestion, where one of the three AccI sites £anks the ctxA gene, a
V280 bp cassette was removed from the 3P-end of the zot gene. This
‘missing’ cassette was reconstructed using recursive polymerase chain
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CATTTTCTGTCTTTATCGGTAAACCA. The 3P-truncated zot gene
was ampli¢ed from the genomic DNA using the primers GAGGATC-
CATCTTTATTCATCACGGCGCG (fwd) and TAGAAGCTTAG-
GCGATAACGCTCATCAC (rev), digested with BamHI and HindIII
and ligated into similarly digested pBluescript II KS (Stratagene). This
construct was then digested with HindIII and KpnI so that the sim-
ilarly digested 286 bp recursive PCR cassette could be ligated in frame
in order to a¡ord the full-length zot gene. The HindIII site was mu-
tated back to the original zot sequence using the Quikchange protocol
(Stratagene) and the zot cassette subcloned into pQE-80L (His-tag,
Qiagen), at BamHI and KpnI sites, and then pMal-c2x (MBP fusion,
NEB), at BamHI and HindIII sites. DNA sequences of all plasmid
constructs were veri¢ed on a PE ABI 377 DNA Sequencer using
dRhodamine Dye Terminator chemistry.
2.2. ZOT expression in Escherichia coli
The E. coli strains DH5K, BLR and AD494 (Novagen) were
screened for expression of ZOT from the pQE-80L/zot and pMal-
c2x/zot constructs, grown at either 30‡C or 37‡C in Lennox broth
containing 100 Wg/ml ampicillin. The DH5K strain, grown at 37‡C,
was considered the most suitable. Cells were grown to an OD600 of
0.6, expression induced by addition of 0.1 mM isopropyl-L-D-1-thio-
galactopyranoside (IPTG) and harvested 3 h later (yield around 3 g/l).
Titration of IPTG concentration versus ZOT expression showed that
0.1 mM was optimal.
2.3. ZOT puri¢cation and refolding
For expression of His-tagged ZOT, the cell pellet was lysed in 6 M
guanidine^HCl (GuHCl) for 30 min, centrifuged at 80 000Ug for 1 h
and loaded directly onto a 15 ml Ni2þ-Sepharose column, washed and
eluted with 40 mM and 250 mM imidazole, respectively. Fractions
containing ZOT were pooled, ZOT precipitated in 90% ethanol on ice
and redissolved in 6 M GuHCl, phosphate-bu¡ered saline (PBS), pH
7.4. Removal of the 33 kDa N-terminal ZOT fragment was achieved
by size exclusion on a Superdex 75 column run on an AKTA FPLC
system (Amersham Biosciences), equilibrated in 4 M GuHCl, PBS.
For expression of maltose binding protein^ZOT (MBP-ZOT), the
cell pellet was lysed by addition of lysozyme (1 mg/ml), 0.01% Triton
X100 in PBS for 30 min at 4‡C and centrifuged at 80 000Ug. MBP-
ZOT was refolded from the solubilised inclusion body fraction (6 M
GuHCl) by 100-fold dilution into Tris^HCl, 0.1% Triton X-100, 5%
glycerol, pH 7.5, concentrated (Millipore YM10 membrane) and par-
tially puri¢ed by size exclusion on a Superdex 200 column. Protein
purity was assessed by Coomassie staining of gels run in a sodium
dodecyl sulphate^polyacrylamide gel electrophoresis system (Minipro-
tean, Bio-Rad). Concentrations of His-tagged ZOT were determined
at A280 with a calculated molar extinction coe⁄cient (O) of 59 720 M31
cm31.
2.4. Enzyme-linked immunosorbent assay (ELISA)
Quantitative assessment of MBP-ZOT concentrations was made by
ELISA, against a standard curve for MBP. 96-well £at-bottomed
plates (Fisher) were coated with doubling dilutions of MBP-ZOT or
MBP in PBS, washed and blocked with 5% bovine serum albumin
(BSA) for 1 h at 37‡C. Wells were washed, incubated for 2 h, at 37‡C,
with mouse anti-MBP antibody (1:2000 dilution in 1% BSA, PBS)
(Sigma), washed, and incubated for 1 h, at room temperature, with
rabbit anti-mouse IgG peroxidase-conjugated antibody (1:2500 dilu-
tion) (Sigma). Wells were washed and substrate added (Sigma Fast1
OPD tablet set) according to the manufacturer’s instructions. A405
was measured with background antibody binding in the absence of
ligand subtracted from the readings.
2.5. Cell culture
Caco-2 cells were obtained from the European collection of cell
culture (ECACC) and used between passage numbers 30 and 35. Cells
were grown in Eagle’s minimum essential medium (Sigma) supple-
mented with 10% foetal calf serum (Invitrogen), 2 mM L-glutamine
(Invitrogen), 1% non-essential amino acids (Invitrogen), and 100 U/ml
penicillin and 100 Wg/ml streptomycin (Invitrogen). Cells were grown
in 75 cm3 £asks and maintained at 37‡C and 5% CO2 in a humidi¢ed
incubator.
2.6. Immunogold labelling and SEM
Caco-2 cells were grown on glass coverslips for 5^7 days until con-
£uent, washed with PBS and incubated in 1 Wg/ml MBP-ZOT for 30
min at 37‡C. Cells were washed, pre¢xed in 4% paraformaldehyde for
20 min and washed with 0.3 M glycine in PBS for 20 min. Cells were
blocked for 15 min in block bu¡er solution with normal goat serum
(Aurion, The Netherlands), washed in 0.1% BSA-c (Aurion) and in-
cubated with mouse anti-MBP (1:2000 dilution) for 1 h. Following
washes with 0.1% BSA-c, cells were incubated with 1/500 dilution of
anti-mouse IgG gold conjugate (10 nm; Sigma) for 1 h. Cells were
¢xed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.2) for
30 min, and incubated in silver enhancing solution (Aurion) for 10
min in the dark. Following washes in 0.1 M sodium cacodylate, cells
were ¢xed in osmium tetroxide and dehydrated in acetone. Cells were
viewed in a JEOL JSM6310 SEM with secondary and backscatter
electron imaging. Non-paired t-test was made for gold particles within
and outside a band equivalent to 1 Wm around the periphery of cells in
contact (for 40 cells, 308 particles).
2.7. Equilibrium chemical denaturation
Experiments were performed for puri¢ed His-tagged ZOT in 1^6 M
GuHCl, PBS. The molarity of the GuHCl solution was calculated by
weight [18]. Protein samples (A280W0.3) were rapidly diluted 11-fold
in GuHCl and allowed to equilibrate for 10 min at 25‡C before mea-
suring £uorescence emitted at 350 nm over a 10 s period, using an
excitation wavelength of 278 nm on a PTI spectro£uorometer, at
25‡C. vGðH2OÞ was calculated by extrapolation to 0 M GuHCl, ¢tting
the data to a two-state unfolding mechanism for the ¢rst transition
step and extrapolating for lack of baseline £uorescence at low GuHCl
concentrations [18,19].
2.8. Circular dichroism (CD)
Spectra were recorded on a JASCO J-600 spectropolarimeter for
puri¢ed His-tagged ZOT in 2 M GuHClðaqÞ at a concentration of
V0.77 mg/ml (A280 1.0). CD measurements were made in quartz cells
with a path length of 0.05 cm for studies conducted in the peptide
region (200^250 nm) and 1.0 cm in the disulphide-aromatic region
(240^360 nm). Baseline corrections of the raw data and conversion
of vA to vO were performed using a mean amino acid mass of 115.
3. Results
3.1. Protein expression
Puri¢cation of His-tagged ZOT by metal chelation yielded
two bands, one at V33 kDa and the other at V45 kDa, the
same pro¢le as reported by Uzzau et al. [9] (Fig. 1). Size
exclusion chromatography isolated the full-length His-tagged
ZOT, which remained stable. Refolding of His-tagged ZOT in
aqueous bu¡er to concentrations required for spectroscopic
analysis was not possible below 1^2 M GuHCl. The possible
role of disulphide formation (ZOT has four Cys residues) in
the folding pathway was investigated via expression in E. coli
thioredoxin reductase mutants (strain AD494) and refolding
in mixed redox bu¡ers (reduced:oxidised glutathione, 5:0.5
mM) but no improved expression or refolding was observed.
MBP-ZOT was similarly expressed in the inclusion body
fraction but refolding into aqueous bu¡er was possible, prob-
ably facilitated by the MBP carrier. Since the refolded fusion
protein showed no a⁄nity for amylose-conjugated Sepharose
resin it appears that soluble intermediates were formed during
the refolding process. Again, no requirement for disulphide
formation in refolding was evident using the same procedures
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as for His-tagged ZOT. Partial puri¢cation of MBP-ZOT via
size exclusion to V50% homogeneity by ELISA analysis was
made.
3.2. Structural stability and conformational organisation of
ZOT
His-tagged ZOT unfolding via GuHCl showed an increase
in £uorescence, implying an overall burying of Trp residues
(eight) in the native conformation (Fig. 2). For unfolded or
folded conformers in a two-state model, the observed two-step
transition is suggestive of two domains of di¡ering conforma-
tional stability. However, this assumption does not always
hold since known domain pairs may unfold co-operatively
[19], and two or more transitions may represent unfolding
via structural intermediates. For this reason we sought con-
formational characterisation of ZOT via CD and ab initio
modelling using HMMSTR secondary structure prediction
[20]. At a concentration of 2 M GuHCl, CD spectra in the
peptide region (Fig. 3) are representative of a random coil
implying at least partial unfolding over the entire sequence.
Further, no secondary structure repeats characteristic of de-
¢ned domains (such as immunoglobulin and C-type lectin
domains seen for invasin and intimin) were predicted for
ZOT using the HMMSTR algorithm. Therefore, the plateau
in the protein unfolding curve most probably exists due to the
presence of structural intermediates; higher GuHCl concen-
trations leading to complete unfolding. The His tag itself is
not expected to contribute to changes in £uorescence since it
is accepted that the tag is structurally non-de¢ned and con-
tains no Trp residues. vGðH2OÞ for ZOT was calculated as 3.82
kcal/mol, corresponding to a protein of poor structural stabil-
ity as may be expected from the refolding experiments [19]
(Fig. 4). No contribution from disulphides or Trp was ob-
served for CD spectra in the disulphide-aromatic region
(data not shown), the absence of disulphides being consistent
with the protein expression and refolding data.
3.3. Localisation of the ZOT receptor
For backscatter images of cells incubated with MBP-ZOT,
silver-coated gold particles were clearly observed as ‘white
dots’, with X-ray analysis of the white dots showing peaks
corresponding to silver. The images suggest that MBP-ZOT
localised to the boundary between con£uent Caco-2 cells (Fig.
5A,B), and a statistically signi¢cant di¡erence (P6 0.01) was
Fig. 1. Expression and puri¢cation of His-tagged ZOT. Lane 1:
markers, kDa; lane 2: crude cell pellet; lane 3, wash; lane 4, elu-
tion. Arrow: His-tagged ZOT; star: 33 kDa N-terminal ZOT frag-
ment.
Fig. 2. GuHCl-induced denaturation of puri¢ed His-tagged ZOT,
showing two transition regions.
Fig. 3. CD spectra for His-tagged ZOT in 2 M GuHClðaqÞ, indica-
tive of a random coil.
Fig. 4. Linear regression analysis for the calculation of vGðH2OÞ for
His-tagged ZOT for the ¢rst transition in the unfolding curve
(slope, m=2.3 kcal/mol M).
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found between the means for the populations of gold particles
within and outside a 1 Wm region at the cell contacts (Fig. 6).
MBP-ZOT was also seen to bind to isolated Caco-2 cells
showing partial detachment from the surface (Fig. 5C), sug-
gesting that processing of the ZOT receptor to the cell mem-
brane is not dependent on cell attachment^polarisation. Too
few partially detached cells prevented their statistical analysis
for receptor localisation. Analysis of 20% and 50% con£uent
monolayers was attempted but isolated cells commonly de-
tached during preparation for SEM and, since the cells
grow in patches, intercellular contacts are as for the 100%
con£uent monolayer. MBP (control) showed no a⁄nity for
the cell surface (Fig. 5D); the ‘white £ecks’ seen in these
backscatter images are distinct from the white dots of gold
colloid. X-ray analysis of these white £ecks con¢rmed the
absence of silver but presence of osmium.
4. Discussion
A preliminary structural analysis of ZOT is provided, CD
and protein unfolding data demonstrating that full-length
ZOT is structurally unstable in solution, undergoing rapid
unfolding in mild denaturant. Thus, it is not surprising that
we have observed poor refolding characteristics for GuHCl-
denatured His-tagged ZOT, especially since refolding of ZOT
appears to proceed via intermediate conformers. The poor
Fig. 5. SEM images of Caco-2 cells labelled for the ZOT receptor with gold colloid. A,B: Representative images of con£uent cells incubated
with MBP-ZOT. C: Isolated cell detaching from the surface incubated with MBP-ZOT. D: Cells incubated with MBP (control).
Fig. 6. Percentage of gold particles within and outside the 1 Wm re-
gion for cell contact, error bars show S.E.M.
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conformational stability of ZOT isolated in aqueous solution
is consistent with evidence that ZOT is a membrane-spanning
protein [9], with hydropathy analysis of ZOT proposing a
transmembrane segment over residues 220^235 [21]. The CD
spectra and refolding data provide evidence that disulphide
formation is not required for the proper folding of ZOT.
This is consistent with the observation that two cysteines lie
within the N-terminal fragment exposed to the reducing mi-
lieu of the bacterium [9], and Cys289-Cys294 oxidation is highly
unlikely given the unfavourable entropy change over the pep-
tide backbone.
It is interesting to note that while refolding of MBP-ZOT
did not yield a native conformation for MBP or ZOT, speci¢c
binding to the putative ZOT receptor on Caco-2 cells was still
observed. This provides a structural basis for the observed
partial inhibition of ZOT activity by an inherently £exible
octapeptide, GGVLVQPG [10]. This scenario is similar to
mimicry of the cell adhesion activity of ¢bronectin by the
RGD tripeptide, for which the mechanism is now known to
be a consequence of the RGD motif residing on a £exible loop
protruding from the 10th type III ¢bronectin domain [22].
Finally, we show that the ZOT receptor is not merely
randomly distributed at the cell surface, as would be su⁄cient
to initiate actin depolymerisation, but localises to intercellular
contacts. This suggests that the ZOT receptor may be associ-
ated with tight junction-associated proteins such as ZO-1,
which would not be surprising given its action. However,
our data are not entirely consistent with images of ZOT-con-
jugated £uorescent microspheres bound to cells, showing a
more dispersed distribution [12]. The di¡erence may be that
these previously reported cell images are not indicative of a
con£uent monolayer and presents the possibility that the
ZOT receptor migrates to the cell periphery during cell^cell
contact. Uzzau et al. [12] also suggested that the ZOT recep-
tor was internalised but unfortunately no z-axis image or sta-
tistical analysis of the cells were provided; our SEM images
are not able to provide evidence for or against internalisation
of the receptor. Further work needs to be directed to the
potential interaction of the ZOT receptor with the tight junc-
tion-associated proteins, possibly via co-immunoprecipitation
experiments, and how this is in£uenced by the binding of
ZOT.
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